Vishar Portfolio Investment Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-07-2024
- Paid Up Capital ₹ 4.05 M
as on 30-07-2024
- Company Age 30 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 89.31%
(FY 2023)
- Profit -9.13%
(FY 2023)
- Ebitda -14.57%
(FY 2023)
- Net Worth -5.22%
(FY 2023)
- Total Assets -6.00%
(FY 2023)
About Vishar Portfolio Investment
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.05 M, as per Ministry of Corporate Affairs (MCA) records.
Subramanian Vasudevan and Gita Vasudevan serve as directors at the Company.
- CIN/LLPIN
U65993TG1994PTC017232
- Company No.
017232
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1994
- Date of AGM
29 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hydeabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vishar Portfolio Investment?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramanian Vasudevan  | Managing Director | 03-May-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gita Vasudevan | Director | 23-Mar-1994 | Current |
Financial Performance of Vishar Portfolio Investment.
Vishar Portfolio Investment Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 89.31% increase. The company also saw a slight decrease in profitability, with a 9.13% decrease in profit. The company's net worth dipped by a decrease of 5.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vishar Portfolio Investment?
In 2023, Vishar Portfolio Investment had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Malladi Drugs And Pharmaceuticals LimitedActive 44 years 5 monthsSubramanian Vasudevan is a mutual person
Sandor Life Sciences Private LimitedActive 20 years 6 monthsSubramanian Vasudevan is a mutual person
Celix Pharmaceuticals (India) Private LimitedActive 6 months 4 daysSubramanian Vasudevan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vishar Portfolio Investment?
Unlock and access historical data on people associated with Vishar Portfolio Investment, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vishar Portfolio Investment, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vishar Portfolio Investment's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
